4-(6-Chloro-pyridin-3-ylmethyl)-piperazine-1-carboxylic acid tert-butyl ester, 95.0%, 1g

6-Bromo-2-fluoro-3-methoxypyridine, 95.0%, 250mg

Boc-D-4,4-Biphenylalanine, 95.0%, 1g

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-nitrophenyl)propanoic acid, 95+%, 500mg

2-BOC-2-AZASPIRO[3.5]NONANE-7-METHANOL, 95.0%, 500mg

(4-FLUOROPYRIDIN-2-YL)METHANOL, 95.0%, 100mg

4-Iodo-6-(methylthio)pyrimidine, 95+%, 250mg

[1-(3-aminopropyl)piperidin-3-yl]methanol, 95.0%, 10g

2,2-dimethyl-3,4-dihydro-2H-1-benzopyran, 95.0%, 100mg

5-BROMO-4-CHLORO-7-(TRIISOPROPYLSILYL)-7H-PYRROLO[2,3-D]PYRIMIDINE, 95%, 250mg

(4s)-4-Isopropyl-5,5-diphenyl-3-[(2r,3s)-4,4,4-trifluoro-3-hydroxy-2,3-dimethyl-butanoyl]oxazolidin-2-one, 98%, 10g

5-metoxiindol, mínimo 98 %, para síntesis, 1 g, envase de vidrio

(R)-2-Amino-3-(3-(trifluoromethyl)phenyl)propanoic acid, 95.0%, 250mg